- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 90,560 | 06.06.24 21:46:46 | -0,280 | -0,31% | 0,000 | 0,000 | 90,100 | 90,840 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 918,200 | 06.06.24 08:10:21 | -1,800 | -0,20% | 0,000 | 0,000 | 918,200 | 920,000 |
